| 臺大學術典藏 |
2020-03-05T06:05:32Z |
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan
|
LI-KAI TSAI; Lin H.-J.; Chua S.-K.; Liao P.-C.; Yang Y.-P.; Chou P.-C.; Lee C.-W.; Lin M.-J.; Chen H.-M.; Yeh J.-T.; Li Y.-H. |
| 臺大學術典藏 |
2020-03-05T06:05:29Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; LI-KAI TSAI; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-03-04T09:03:09Z |
The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
|
Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:08Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Chau-Chung Wu;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Wang C.-Y.;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L.; Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; CHAU-CHUNG WU; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T05:42:45Z |
2017 Taiwan lipid guidelines for high risk patients
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:38Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T05:42:36Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L.; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:32Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-03-04T05:35:03Z |
Theory of mind in patients with temporal lobe epilepsy
|
Li Y.-H.; MING-JANG CHIU; Yeh Z.-T.; Liou H.-H.; Cheng T.-W.; Hua M.-S. |
| 臺大學術典藏 |
2020-03-02T12:10:57Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:46Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:43Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
SUNG-CHUN TANG;Lin J.-L.;Hwang J.-J;Wu Y.-W;Yang Y.-C;Chan H.-L;Tsai L.-K;Fu W.-R;Chao A.-C;Lee M.-Y;Wang C.-Y;Huang W.-C;Chang W.-T;Chen Z.-C;Huang C.-W;Chen P.-W;Wu C.-K;Chang K.-C;Huang C.-C;Yeh H.-I;Wu C.-C;Wang Y.-C;Lin T.-H;Chen J.-W;Li Y.-H; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I; Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L. |
| 臺大學術典藏 |
2020-03-02T12:10:30Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
SUNG-CHUN TANG;Yeh H.-I.;Li Y.-H;Huang Y.-H;Chen P.-S;Chien S.-C; Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-03-02T07:40:40Z |
A method to prepare magnetic nanosilicate platelets for effective removal of microcystis aeruginosa and microcystin-LR
|
Chang, S.-C.; Lu, B.-L.; Lin, J.-J.; Li, Y.-H.; Lee, M.-R.; JIANG-JEN LIN |
| 臺大學術典藏 |
2020-02-27T07:42:46Z |
2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension
|
Chiang C.-E.; Wang T.-D.; Ueng K.-C.; Lin T.-H.; Yeh H.-I.; Chen C.-Y.; Wu Y.-J.; Tsai W.-C.; Chao T.-H.; Chen C.-H.; Chu P.-H.; Chao C.-L.; Liu P.-Y.; Sung S.-H.; Cheng H.-M.; Wang K.-L.; Li Y.-H.; Chiang F.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Lin S.-J.; Lin S.-J.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Chiang F.-T.;Li Y.-H.;Wang K.-L.;Cheng H.-M.;Sung S.-H.;Liu P.-Y.;Chao C.-L.;Chu P.-H.;Chen C.-H.;Chao T.-H.;Tsai W.-C.;Wu Y.-J.;Chen C.-Y.;Yeh H.-I.;Lin T.-H.;Ueng K.-C.;Wang T.-D.;Chiang C.-E. |
| 臺大學術典藏 |
2020-02-27T07:42:37Z |
The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension
|
Lin J.-L.; Lin J.-L.;Lin S.-J.;Chen M.-F.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Lai W.-T.;Chiang F.-T.;Wang K.-Y.;Li Y.-H.;Wang K.-L.;Sung S.-H.;Chu P.-H.;Chen C.-Y.;Ueng K.-C.;Shyu K.-G.;Chen C.-H.;Chao T.-H.;Cheng H.-M.;Liu P.-Y.;Yeh H.-I.;Lin T.-H.;Wang T.-D.;Chiang C.-E.; Chiang C.-E.; Wang T.-D.; Lin T.-H.; Yeh H.-I.; Liu P.-Y.; Cheng H.-M.; Chao T.-H.; Chen C.-H.; Shyu K.-G.; Ueng K.-C.; Chen C.-Y.; Chu P.-H.; Sung S.-H.; Wang K.-L.; Li Y.-H.; Wang K.-Y.; Chiang F.-T.; Lai W.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Chen M.-F.; Lin S.-J. |
| 臺大學術典藏 |
2020-02-25T09:38:31Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai, H.-S.;Tseng, W.-K.;Yin, W.-H.;Fang-Ju Lin;Hsuan, C.-F.;Wu, Y.-W.;Huang, L.-C.;Lin, T.-H.;Chang, K.-C.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.; Tsai, H.-S.; Tseng, W.-K.; Yin, W.-H.; FANG-JU LIN; Hsuan, C.-F.; Wu, Y.-W.; Huang, L.-C.; Lin, T.-H.; Chang, K.-C.; Li, Y.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-19T07:21:49Z |
Suppression of COUP-TFII by proinflammatory cytokines contributes to the pathogenesis of endometriosis
|
Lin S.-C.; Li Y.-H.; Wu M.-H.; Chang Y.-F.; Lee D.-K.; Tsai S.Y.; Tsai M.-J.; Tsai S.-J.; MING-JER TSAI |
| 臺大學術典藏 |
2020-02-07T08:48:56Z |
Mitral valve aneurysm and infective endocarditis: report of four cases.
|
Lien W.P.;Kuan P.;Hwang J.J.;MATTHEW HUEI-MING MA;Wang T.L.;Lei M.H.;Lin J.M.;Li Y.H.; Li Y.H.; Lin J.M.; Lei M.H.; Wang T.L.; MATTHEW HUEI-MING MA; Hwang J.J.; Kuan P.; Lien W.P. |
